This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DeMeester, S. R. Search for Related Content PubMed PubMed Citation Articles by DeMeester, S. R.

Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its Treatment

Department of Cardiothoracic Surgery, The University of Southern California, Keck School of Medicine, 1510 San Pablo Street, Suite 514, Los Angeles, California 90033

Correspondence: Address correspondence and reprint requests to: Steven R. DeMeester, MD; E-mail: sdemeester{at}surgery.usc.edu

Background: Over the past 50 years there has been a remarkable change in the epidemiology of esophageal cancer. Previously rare, adenocarcinoma of the esophagus and gastroesophageal junction is now the most common esophageal cancer, and in the United States the incidence is increasing faster than that of any other malignancy. Surveillance in patients with Barrett’s esophagus is identifying adenocarcinoma at an earlier, more curable stage in many patients, and at the same time new endoscopic and surgical options are available for the therapy of these localized tumors.

Methods: This article is a review of the epidemiology, diagnosis, staging, and treatment options for esophageal and gastroesophageal junction adenocarcinoma.

Results: The epidemiology, prognosis, patterns of lymphatic metastasis, and survival for esophageal and gastroesophageal junction adenocarcinoma suggest that these tumors are similar. New options for therapy, as well as the results of surgical resection with and without chemoradiotherapy, are reviewed.

Conclusions: Surveillance programs for Barrett’s are identifying patients with early, curable adenocarcinoma of the esophagus or gastroesophageal junction. Therapy for more advanced tumors hinges on local control of the disease and the eradication of systemic metastases.

Key Words: Esophageal adenocarcinoma • Cardia • Review • Treatment • Barrett’s esophagus

This article has been cited by other articles:

				A. Babu, X. Meng, A. M. Banerjee, F. Gamboni-Robertson, J. C. Cleveland, S. Damle, D. A. Fullerton, and M. J. Weyant Secretory phospholipase A(2) is required to produce histologic changes associated with gastroduodenal reflux in a murine model. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1220 - 1227. [Abstract] [Full Text] [PDF]

				C. Rizzetto, S.R. DeMeester, J.A. Hagen, C.G. Peyre, J.C. Lipham, and T.R. DeMeester En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1228 - 1236. [Abstract] [Full Text] [PDF]

				A. J. Greenstein, V. R. Litle, S. J. Swanson, C. M. Divino, S. Packer, T. G. McGinn, and J. P. Wisnivesky Racial Disparities in Esophageal Cancer Treatment and Outcomes Ann. Surg. Oncol., March 1, 2008; 15(3): 881 - 888. [Abstract] [Full Text] [PDF]

				J. F. Bruzzi, R. F. Munden, M. T. Truong, E. M. Marom, B. S. Sabloff, G. W. Gladish, R. B. Iyer, T.-S. Pan, H. A. Macapinlac, and J. J. Erasmus PET/CT of Esophageal Cancer: Its Role in Clinical Management RadioGraphics, November 1, 2007; 27(6): 1635 - 1652. [Abstract] [Full Text] [PDF]

				S. Rauser, R. Weis, H. Braselmann, M. Feith, H. J. Stein, R. Langer, P. Hutzler, M. Hausmann, S. Lassmann, J. R. Siewert, et al. Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence In situ Hybridization Testing in Tissues Clin. Cancer Res., September 1, 2007; 13(17): 5115 - 5123. [Abstract] [Full Text] [PDF]

				S. Mattioli, A. Ruffato, M. P. Di Simone, B. Corti, A. D'Errico, M. L. Lugaresi, B. Mattioli, and F. D'Ovidio Immunopathological Patterns of the Stomach in Adenocarcinoma of the Esophagus, Cardia, and Gastric Antrum: Gastric Profiles in Siewert Type I and II Tumors Ann. Thorac. Surg., May 1, 2007; 83(5): 1814 - 1819. [Abstract] [Full Text] [PDF]

				L. F. Onate-Ocana, G. Milan-Revollo, V. Aiello-Crocifoglio, J. F. Carrillo, D. Gallardo-Rincon, R. Brom-Valladares, R. Herrera-Goepfert, and A. Duenas-Gonzalez Treatment of the Adenocarcinoma of the Esophagogastric Junction at a Single Institution in Mexico Ann. Surg. Oncol., April 1, 2007; 14(4): 1439 - 1448. [Abstract] [Full Text] [PDF]

				Q. Huang and L. H. Zhang The Histopathologic Spectrum of Carcinomas Involving the Gastroesophageal Junction in the Chinese International Journal of Surgical Pathology, January 1, 2007; 15(1): 38 - 52. [Abstract] [PDF]

				J. Sims-Mourtada, J. G. Izzo, S. Apisarnthanarax, T.-T. Wu, U. Malhotra, R. Luthra, Z. Liao, R. Komaki, A. van der Kogel, J. Ajani, et al. Hedgehog: an Attribute to Tumor Regrowth after Chemoradiotherapy and a Target to Improve Radiation Response. Clin. Cancer Res., November 1, 2006; 12(21): 6565 - 6572. [Abstract] [Full Text] [PDF]